ADDEX THERAPEUTICS LTD.

Profile

Company Names

ADDEX THERAPEUTICS LTD.

Addresses

CHEMIN DES MINES 9, GENEVA, V8 CH-1202

Phone Numbers

01141228841555

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

SWITZERLAND

Total Amount Raised:

$13,898,952.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-04-05 
$3,733,334.00 
$3,733,334.00 
$0.00 
Equity 
2
2022-07-22 
$4,230,500.00 
$4,230,500.00 
$0.00 
Equity 
1
2021-12-21 
$5,935,118.00 
$5,935,118.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIMOTHY 
 
DYER 
EXECUTIVE OFFICER, DIRECTOR
ADDEX THERAPEUTICS LTD.
RAYMOND 
 
HILL 
DIRECTOR
SHEPHERD I L P   |  INVENTIV HEALTH INC   |  CONCENTRATED OPPORTUNITIES FUND, LP   |  PROGNOS HEALTH INC.   |  ADDEX THERAPEUTICS LTD.
MIKHAIL 
 
KALINICHEV 
EXECUTIVE OFFICER
ADDEX THERAPEUTICS LTD.
VINCENT 
 
LAWTON 
DIRECTOR
ADDEX THERAPEUTICS LTD.
ROBERT 
 
LUTJENS 
EXECUTIVE OFFICER
ADDEX THERAPEUTICS LTD.
ISAAC 
 
MANKE 
DIRECTOR
ONKURE, INC.   |  ADDEX THERAPEUTICS LTD.   |  ONKURE THERAPEUTICS, INC.
ROGER 
 
MILLS 
EXECUTIVE OFFICER, DIRECTOR
ADDEX THERAPEUTICS LTD.   |  ENTERIN, INC.   |  MILLS ELOGE INVESTMENTS, LLC, SERIES 2   |  MILLS ELOGE INVESTMENTS, LLC, SERIES 4   |  MILLS ELOGE INVESTMENTS, LLC, SERIES 3
JAKE 
 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  TV2 HOLDING CO   |  ACIEX THERAPEUTICS, INC.   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  ADDEX THERAPEUTICS LTD.   |  ZENAS BIOPHARMA, INC.
JEAN-PHILIPPE 
 
ROCHER 
EXECUTIVE OFFICER
ADDEX THERAPEUTICS LTD.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-04-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-05 
2022-08-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-22 
2021-12-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375